| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 102.598 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.427 | 26.440 |
| Total Income - EUR | 103.025 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 3.427 | 26.455 |
| Total Expenses - EUR | 101.981 | 117 | 0 | 0 | 0 | 38 | 0 | 0 | 12.136 | 48.318 |
| Gross Profit/Loss - EUR | 1.043 | -87 | 0 | 0 | 0 | -38 | 0 | 0 | -8.710 | -21.863 |
| Net Profit/Loss - EUR | 876 | -87 | 0 | 0 | 0 | -38 | 0 | 0 | -8.710 | -21.863 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
Check the financial reports for the company - Reborn Terapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.414 | 24.628 |
| Current Assets | 8.608 | 826 | 812 | 797 | 782 | 730 | 713 | 716 | 3.290 | 23 |
| Inventories | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 801 | 0 |
| Receivables | 7.372 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.941 | 0 |
| Cash | 1.231 | 821 | 808 | 793 | 777 | 725 | 709 | 711 | 548 | 22 |
| Shareholders Funds | 921 | 825 | 811 | 796 | 781 | 728 | 712 | 714 | -7.997 | -29.815 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.687 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 29.702 | 54.466 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Reborn Terapy S.r.l.